Your browser doesn't support javascript.
loading
Programmable Nuclease-Based Integration into Novel Extragenic Genomic Safe Harbor Identified from Korean Population-Based CNV Analysis.
Lee, Eun-Seo; Moon, Sanghoon; Abu-Bonsrah, Kwaku Dad; Kim, Yun Kyoung; Hwang, Mi Yeong; Kim, Young Jin; Kim, Seokjoong; Hwang, Nathaniel S; Kim, Hyongbum Henry; Kim, Bong-Jo.
Afiliación
  • Lee ES; Department of Pharmacology, Yonsei University College of Medicine, Seoul 03372, Republic of Korea.
  • Moon S; School of Chemical and Biological Engineering, Seoul National University, Seoul 08826, Republic of Korea.
  • Abu-Bonsrah KD; Division of Genome Research, Center for Genome Science, Korea National Institute of Health, Chungcheongbuk-do 28159, Korea.
  • Kim YK; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC 3052, Australia.
  • Hwang MY; Division of Genome Research, Center for Genome Science, Korea National Institute of Health, Chungcheongbuk-do 28159, Korea.
  • Kim YJ; Division of Genome Research, Center for Genome Science, Korea National Institute of Health, Chungcheongbuk-do 28159, Korea.
  • Kim S; Division of Genome Research, Center for Genome Science, Korea National Institute of Health, Chungcheongbuk-do 28159, Korea.
  • Hwang NS; ToolGen, Seoul 08501, Republic of Korea.
  • Kim HH; School of Chemical and Biological Engineering, Seoul National University, Seoul 08826, Republic of Korea.
  • Kim BJ; Interdisciplinary Program in Bioengineering, Seoul National University, Seoul 08826, Republic of Korea.
Mol Ther Oncolytics ; 14: 253-265, 2019 Sep 27.
Article en En | MEDLINE | ID: mdl-31463366
ABSTRACT
Here, we found two genomic safe harbor (GSH) candidates from chromosomes 3 and 8, based on large-scale population-based cohort data from 4,694 Koreans by CNV analysis. Furthermore, estimated genotype of these CNVRs was validated by quantitative real-time PCR, and epidemiological data examined no significant genetic association between diseases or traits and two CNVRs. After screening the GSH candidates by in silico approaches, we designed TALEN pairs to integrate EGFP expression cassette into human cell lines in order to confirm the functionality of GSH candidates in an in vitro setting. As a result, transgene insertion into one of the two loci using TALEN showed robust transgene expression comparable to that with an AAVS1 site without significantly perturbing neighboring genes. Changing the promoter or cell type did not noticeably disturb this trend. Thus, we could validate two CNVRs as a site for effective and safe transgene insertion in human cells.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Año: 2019 Tipo del documento: Article